Quick Answer
Atara Biotherapeutics, Inc. reported Net Income of $32.69 million for fiscal year 2025.
Atara Biotherapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $32.69M | +138.3% |
| 2024 | -$85.40M | +69.1% |
| 2023 | -$276.13M | -20.9% |
| 2022 | -$228.30M | +32.9% |
| 2021 | -$340.14M | -10.9% |
| 2020 | -$306.62M | -5.4% |
| 2019 | -$290.98M | -26.1% |
| 2018 | -$230.70M | -93.1% |
| 2017 | -$119.49M | -51.2% |
| 2016 | -$79.05M | -38.1% |
| 2015 | -$57.22M | -104.3% |
| 2014 | -$28.01M | -219.2% |
| 2013 | -$8.77M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.30M | +80.4% | -280.3% |
| June 30, 2025 | $2.39M | +112.5% | -93.7% |
| March 31, 2025 | $38.01M | +219.7% | +273.5% |
| September 30, 2024 | -$21.91M | +68.6% | -15.0% |
| June 30, 2024 | -$19.05M | +73.2% | +40.0% |
| March 31, 2024 | -$31.75M | +57.5% | +54.5% |
| September 30, 2023 | -$69.80M | +17.0% | +1.8% |
| June 30, 2023 | -$71.11M | -485.1% | +4.9% |
- Atara Biotherapeutics, Inc. showed an increase of +138.3% in Net Income compared to the prior fiscal year.
- Over the 2013–2025 period, Atara Biotherapeutics, Inc.’s net income has grown by 472.6% (from -$8.77 million to $32.69 million).
- The most recent figure is from Atara Biotherapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: